UroGen Pharma Ltd.

RHUMBLINE ADVISERS URGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

45,760

Value ($000)

1,072

Weight

0.0%

2019 Q4 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	1,072	0.0%	45,760	12/31/2025
2025 Q3	11/6/2025	1,017	0.0%	50,953	9/30/2025
2025 Q2	8/12/2025	703	0.0%	51,293	6/30/2025
2025 Q1	5/29/2025	591	0.0%	53,466	3/31/2025
2024 Q4	5/29/2025	546	0.0%	51,270	12/31/2024
2024 Q3	11/12/2024	633	0.0%	49,868	9/30/2024
2024 Q2	8/1/2024	847	0.0%	50,477	6/30/2024
2024 Q1	5/9/2024	552	0.0%	36,796	3/31/2024
2023 Q4	2/8/2024	521	0.0%	34,706	12/31/2023
2023 Q3	11/9/2023	376	0.0%	26,864	9/30/2023
2023 Q2	8/8/2023	211	0.0%	20,406	6/30/2023
2022 Q1	5/12/2022	202	0.0%	23,152	3/31/2022
2021 Q4	2/10/2022	229	0.0%	24,064	12/31/2021
2021 Q3	11/12/2021	411	0.0%	24,408	9/30/2021
2021 Q2	8/5/2021	365	0.0%	23,903	6/30/2021
2021 Q1	5/6/2021	518	0.0%	26,578	3/31/2021
2020 Q4	2/10/2021	516	0.0%	28,648	12/31/2020
2020 Q3	11/12/2020	492	0.0%	25,517	9/30/2020
2020 Q2	8/13/2020	760	0.0%	29,087	6/30/2020
2020 Q1	5/6/2020	420	0.0%	23,548	3/31/2020
2019 Q4	2/5/2020	781	0.0%	23,405	12/31/2019